You are now leaving this website. By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.
You are now leaving this website. By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co., Inc., Rahway, NJ, USA.
Do you dream of a career dedicated to extending and improving the lives of cancer patients?
Our development programme in immuno-oncology aims to improve life for cancer patients and their families. When you join the Oncology team in the Nordics, you’ll work for life every day by making our breakthrough innovations available to more patients. We are building a leading oncology company—and we need your expertise and passion on our exciting journey. Working closely with medical professionals, legislators and regulators, we offer both scientific and commercial profiles a professionally satisfying career in a fast-moving company, and the opportunity to truly work for life.
Inside views from people on our team
I enjoy following the latest scientific developments and working with clinicians to see how new medicines impact patient care.
Medical Advisor, Oncology, Finland
Scientific exchange with the top medical doctors in the country as well as all my great colleagues is what makes our company special.
Medical Advisor, Oncology, Sweden
Meet Truc Hoang
Medical advisor, Oncology
About Oncology in the Nordics
MSD is a pioneer company in Immuno-Oncology that has the potential to transform how physicians treat cancer and how patients benefit from their cancer treatment. We have an industry-leading global oncology development programme that includes more than 700 clinical trials ongoing, and we expect a significant number of approvals for treatments for different types of cancers over the coming years. MSD’s Oncology team in the Nordics is the scientific and commercial liaison between MSD and national health care providers and authorities. Our team has an unwavering commitment to supporting accessibility and accelerated access to our medicines for those in need, and we are proud of building a leading oncology company.
Cancer diagnoses worldwide since 2012
predicted cancer diagnoses worlwide in 2025
Approximate global clinical trials in our oncology development programme
Approximate clinical trials in the Nordics
Do you want to help our innovation reach more patients?
Join us as a:
Country Medical Lead
Commercial Operations & Alliance Lead
Therapy Area Manager
Visionary science: Immuno-Oncology
Every member of our team is committed to smartly and collaboratively accelerating the speed with which we can bring forward new approaches to treat people with cancer.
Understanding the immune system and cancer
In the 1950s, researchers proposed that the immune system patrols the body to detect and destroy tumor cells. Scientists and researchers had previously focused on cancer cells and treating cancer as a genetic disease.
Now the focus is shifting to the microenvironment in which cancer grows, including the immune system - an approach called Immuno-Oncology.
Immuno-Oncology has the potential to transform how physicians treat cancer and how patients benefit.
This careers website is intended for Residents of Europe, Middle East, Africa, Latin America & Asia Pacific. Residents in the United States, Canada & Puerto Rico, please visit this Careers website. Information on this site is for the purpose of presenting career opportunities at our organisation and give our audience a view of our culture, diversity and growth opportunities. Our Company is an equal opportunity employer, proudly embracing diversity in all of its manifestations.